June 10, 2021
According to the research report titled ‘Mitral Valve Annuloplasty Rings Market Insights, Competitive Landscape and Market Forecast-2026’, available with Market Study Report, global mitral valve annuloplasty rings market is likely to generate substantial revenues by the year 2026.
Technological advancements, growing geriatric population and high occurrence of cardiovascular disorders are some of the key factors fueling global mitral valve annuloplasty rings market. For the record, an annuloplasty ring is basically a band or a ring which is attached to the base of the heart valve in order to support or reshape the targeted valve.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3557547/
These rings or bands are primarily made using durable materials including fabric, plastic, as well as metal and are covered in cloth-like material such as Dacron or polyester. Annuloplasty rings can be offered in various sizes and are available in semi-rigid, rigid, or flexible forms.
Thus, rising popularity of heart valve procedures have impelled the demand for mitral valve annuloplasty rings across the globe, which in turn is favoring the overall market scenario. However, strict approval procedure, high costs associated with the treatment, and lack of product availability could potentially hinder the market expansion in the ensuing years.
As per type, the market is fragmented into into semi-rigid annuloplasty rings, rigid annuloplasty rings, and flexible annuloplasty rings.
The application reach of global mitral valve annuloplasty rings industry comprises of aortic valve annuloplasty, tricuspid valve annuloplasty, mitral valve annuloplasty segments. Citing the end-user spectrum, the industry is categorized into specialty clinics, ambulatory surgery centers, and hospitals.
Geographically, the industry is segmented into Japan, the United Kingdom, Spain, France, Germany, Italy, and the United States.
Top contenders in global mitral valve annuloplasty rings industry are Valcare Medical Inc., St. Jude Medical Inc., The Sorin Group, Labcor Laboratórios Ltda, Braile Biomédica, LivaNova PLC, Abbott Laboratories, Edwards Lifesciences Corp., and Medtronic plc among others.